Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum…

Overview of attention for article published in BMC Cancer, August 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 77 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 363 followers.

[VEGF] Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma ... https://t.co/JQpRpnsdY6 PM

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.